KASKELA LAW LOGO1.jpg
Kaskela Law LLC Announces Shareholder Investigation of Bloomin’ Brands, Inc. (BLMN) and Encourages Investors to Contact the Firm
February 15, 2024 08:00 ET | Kaskela Law
PHILADELPHIA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Bloomin’ Brands, Inc. (NASDAQ: BLMN) (“Bloomin’ Brands”) on behalf of the company’s shareholders. ...
KASKELA LAW LOGO1.jpg
Kaskela Law LLC Announces Shareholder Investigation of Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) and Encourages Investors to Contact the Firm
February 15, 2024 08:00 ET | Kaskela Law
PHILADELPHIA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (“Clear Channel”) on behalf of the company’s...
KASKELA LAW LOGO1.jpg
Kaskela Law LLC Announces Shareholder Investigation of Outlook Therapeutics, Inc. (OTLK) and Encourages Investors to Contact the Firm
February 15, 2024 08:00 ET | Kaskela Law
PHILADELPHIA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Outlook Therapeutics, Inc. (NASDAQ: OTLK) (“Outlook”) on behalf of the company’s shareholders. The...
KASKELA LAW LOGO1.jpg
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Investors to Contact the Firm
February 14, 2024 08:01 ET | Kaskela Law
PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on behalf of the...
KASKELA LAW LOGO1.jpg
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Sotera Health Co. (NASDAQ: SHC) and Encourages Long-Term Investors to Contact the Firm
February 14, 2024 08:01 ET | Kaskela Law
PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Sotera Health Company (NASDAQ: SHC) (“Sotera”) on behalf of the company’s...
KASKELA LAW LOGO1.jpg
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Leslie’s, Inc. (NASDAQ: LESL) and Encourages Long-Term Investors to Contact the Firm
February 14, 2024 08:01 ET | Kaskela Law
PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Leslie’s, Inc. (NASDAQ: LESL) on behalf of the company’s long-term investors. ...
KASKELA LAW LOGO1.jpg
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Bioventus Inc. (NASDAQ: BVS) and Encourages Long-Term Investors to Contact the Firm
February 14, 2024 08:01 ET | Kaskela Law
PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Bioventus Inc. (NASDAQ: BVS) (“Bioventus”) on behalf of the company’s long-term...
KASKELA LAW LOGO1.jpg
Shareholder Investigation of BioAtla, Inc. (NASDAQ: BCAB) Announced by Kaskela Law LLC: Investors Encouraged to Contact the Firm
January 16, 2024 10:11 ET | Kaskela Law
PHILADELPHIA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced a shareholder investigation into BioAtla, Inc. (NASDAQ: BCAB) on behalf of the company’s investors. ...
KASKELA LAW LOGO1.jpg
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Axon Enterprise, Inc. (NASDAQ: AXON) and Encourages Long-Term Investors to Contact the Firm
January 08, 2024 08:00 ET | Kaskela Law
PHILADELPHIA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder protection law firm Kaskela Law LLC announces that it is investigating Axon Enterprise, Inc. (NASDAQ: AXON) (“Axon”) on behalf of the...
KASKELA LAW LOGO1.jpg
AMNEAL INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) and Encourages Investors with Losses to Contact the Firm
December 27, 2023 08:30 ET | Kaskela Law
PHILADELPHIA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) on behalf of the Company’s shareholders. ...